Earlier this month, we published new data from two separate Freedom of Information (FOI) requests providing the most complete and
As Aurora faces down an unsolicited takeover bid from one of the world’s largest cannabis companies, it has continued to
Irish pharmaceutical cannabis manufacturer Dunbar Pharmaceuticals has today launched the first plant-derived dronabinol active ingredient into the UK market. In
More than a year has passed since the Advisory Council on the Misuse of Drugs (ACMD) was commissioned to conduct
Written by Michael Sassano, Founder and Interim CEO, SOMAÍ Pharmaceuticals Most US cannabis companies thinking about Europe focus on the
The UK has another new Prime Minister, Andy Burnham, who has wasted no time in laying out his plans to
Written by Omar Khan, Chief Communications and Public Affairs Officer, High Tide Inc. (HITI) The first challenge facing a new
As new national guidance instructs officers to treat medical cannabis users as patients first, James Duckenfield, CEO of Glass Pharms,
The UK medical cannabis sector has spent seven years arguing for access. The next argument will be settled on outcomes,
New Zealand-listed Rua Bioscience (NZX: RUA) has agreed a sales and distribution deal with one of the UK’s largest medicinal
Written for Business of Cannabis by Saxon Coop, Founder & CEO of Toke. In March, The Times reported that a
New data acquired by Business of Cannabis has, for the first time, shed light on the professional types behind England’s
Curaleaf International has launched a free CPD-accredited online education platform for UK healthcare professionals to help close the training gap
Curaleaf Laboratories, one of the UK’s leading manufacturers and distributors of EU-GMP medical cannabis products and Herdade das Barrocas (HDB),
Since April 2024, Berlin has cemented its place as the spiritual centre of the European cannabis industry. It is home
The UK’s medical cannabis market has long been a locked box when it comes to reliable data. The fact that
Written by Oskar Fletcher, Chief Executive of pharmaceutical contract manufacturing operator Blossom Pharma. Europe’s medical cannabis industry is entering a
Cannabis Europa London returns on 26-27 May 2026, bringing together operators, investors, clinicians and policymakers from across the global cannabis
We won’t spam you
